Geneva, Feb. 13 -- International Clinical Trials Registry received information related to the study (ISRCTN15458209) titled 'Evaluation of the benefits of berberine phospholipids supplementation in subjects with acne prone skin' on Feb. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized controlled trial
Masking: Blinded (masking used)
Control: Placebo
Assignment: Parallel
Purpose: Treatment, Efficacy and Pleasantness
Primary Sponsor: INDENA S.P.A.
Condition:
Healthy volunteers with acne prone skin
Skin and Connective Tissue Diseases
Intervention:
The active intervention is a food supplement based on Berberine Phytosome™ (Berberine Phospholipids), standardized with a content of Berberine ranging from 28% to 3...